Current options and recommendations for the use of thoracic endovascular aortic repair in acute and chronic thoracic aortic disease: an expert consensus document of the European Society for Cardiology (ESC) Working Group of Cardiovascular Surgery, the ESC Working Group on Aorta and Peripheral Vascular Diseases, the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC and the European Association for Cardio-Thoracic Surgery (EACTS)
Why the study?
To provide a synopsis of current evidence regarding the use or non-use of TEVAR in acute and chronic thoracic aortic disease, share recommendations for modified terminology and reporting standards, and outline future developments.
Population
Patients with acute and chronic thoracic aortic disease
Comparison
Use vs non-use of TEVAR
Design
Expert consensus document
Authors
Discussion
Loading...
Member takes
Implication
Updates TEVAR standards for aortic disease; extends prior consensus with new terminology and reporting requirements.
Structured PICO
P
Population
Patients with acute and chronic thoracic aortic disease
I
Intervention
Thoracic endovascular aortic repair (TEVAR)
This ESC/EACTS expert consensus document provides updated recommendations, terminology, and reporting standards for the use of TEVAR in acute and chronic thoracic aortic disease.
Cite This Study
Czerny et al. (2020) conducted a review in Acute and chronic thoracic aortic disease. Thoracic endovascular aortic repair (TEVAR) was evaluated. Thoracic endovascular aortic repair (TEVAR) has become the standard treatment for several acute and chronic diseases of the thoracic aorta, necessitating centralized care and aortic center formation.